EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience

To validate the recently reported European Treatment and Outcomes Study (EUTOS) score, we applied it to 465 patients with early chronic phase chronic myeloid leukemia treated with standard-dose imatinib (n = 71), high-dose imatinib (n = 208), or second-generation tyrosine kinase inhibitors (n = 186)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jabbour, Elias, Cortes, Jorge, Nazha, Aziz, O'Brien, Susan, Quintas-Cardama, Alfonso, Pierce, Sherry, Garcia-Manero, Guillermo, Kantarjian, Hagop
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2012
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3362365/
https://ncbi.nlm.nih.gov/pubmed/22431574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-10-388967
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados